These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM. Rachman J, Gribble FM, Barrow BA, Levy JC, Buchanan KD, Turner RC. Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556 [Abstract] [Full Text] [Related]
29. Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance. Byrne MM, Gliem K, Wank U, Arnold R, Katschinski M, Polonsky KS, Göke B. Diabetes; 1998 Aug; 47(8):1259-65. PubMed ID: 9703326 [Abstract] [Full Text] [Related]
31. Effect of phentolamine on the somatostatin-induced inhibition of glucagon and insulin secretion. Kaneto A, Kajinuma H, Kaneko T, Kosaka K. Metabolism; 1978 Aug; 27(8):901-10. PubMed ID: 209286 [Abstract] [Full Text] [Related]
35. Effect of beta and beta2 adrenoreceptor stimulants infused intrapancreatically on glucagon and insulin secretion. Kaneto A, Miki E, Kosaka K. Endocrinology; 1975 Nov; 97(5):1166-73. PubMed ID: 241626 [Abstract] [Full Text] [Related]
39. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs. Ross G, Lickley L, Vranic M. Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297 [Abstract] [Full Text] [Related]
40. [Effects of experimental hyperammonemia on the secretion of insulin and glucagon in the rat]. Schlienger JL, Sapin R, Imler M. C R Seances Soc Biol Fil; 1980 Feb; 174(2):199-204. PubMed ID: 6446964 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]